IL158385A0 - Modified cyclosporin which can be used as a pro-drug and use thereof - Google Patents

Modified cyclosporin which can be used as a pro-drug and use thereof

Info

Publication number
IL158385A0
IL158385A0 IL15838502A IL15838502A IL158385A0 IL 158385 A0 IL158385 A0 IL 158385A0 IL 15838502 A IL15838502 A IL 15838502A IL 15838502 A IL15838502 A IL 15838502A IL 158385 A0 IL158385 A0 IL 158385A0
Authority
IL
Israel
Prior art keywords
pro
drug
modified cyclosporin
cyclosporin
modified
Prior art date
Application number
IL15838502A
Other languages
English (en)
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Publication of IL158385A0 publication Critical patent/IL158385A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15838502A 2001-04-20 2002-04-22 Modified cyclosporin which can be used as a pro-drug and use thereof IL158385A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH7202001 2001-04-20
PCT/CH2002/000222 WO2002085928A2 (fr) 2001-04-20 2002-04-22 Cyclosporine modifiee utilisable en tant que pro-drogue et son utilisation

Publications (1)

Publication Number Publication Date
IL158385A0 true IL158385A0 (en) 2004-05-12

Family

ID=4531478

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15838502A IL158385A0 (en) 2001-04-20 2002-04-22 Modified cyclosporin which can be used as a pro-drug and use thereof

Country Status (17)

Country Link
US (1) US6995139B2 (xx)
EP (1) EP1379547B1 (xx)
JP (1) JP4588979B2 (xx)
KR (1) KR100932859B1 (xx)
CN (1) CN1507451A (xx)
AT (1) ATE313557T1 (xx)
AU (1) AU2002245996B8 (xx)
BR (1) BR0208923A (xx)
CA (1) CA2444278C (xx)
DE (1) DE60208180T2 (xx)
ES (1) ES2256450T3 (xx)
IL (1) IL158385A0 (xx)
MX (1) MXPA03009586A (xx)
RU (1) RU2290196C2 (xx)
UA (1) UA75136C2 (xx)
WO (1) WO2002085928A2 (xx)
ZA (1) ZA200307794B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7354574B2 (en) * 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
CA2615990A1 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7531572B2 (en) 2006-07-28 2009-05-12 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use
US8394763B2 (en) 2007-09-26 2013-03-12 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
KR102305423B1 (ko) 2010-12-15 2021-09-27 콘트라빌 파마슈티컬스, 인코퍼레이티드 아미노산 1 및 3에서 변형된 사이클로스포린 유사체 분자
AR090964A1 (es) * 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos
CN113388002A (zh) * 2021-06-10 2021-09-14 梯尔希（南京）药物研发有限公司 一种环孢菌素相关化合物的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU548156B2 (en) * 1980-02-14 1985-11-28 Novartis Ag Cyclo sporin
US4396542A (en) * 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
US5169773A (en) * 1984-10-04 1992-12-08 Sandoz Ltd. Monoclonal antibodies to cyclosporins
ATE43499T1 (de) * 1984-10-10 1989-06-15 Ile De France Synergistische empfaengnisverhuetende mischung.
US4764503A (en) * 1986-11-19 1988-08-16 Sandoz Ltd. Novel cyclosporins
ES2095926T5 (es) * 1990-11-02 2001-02-16 Novartis Ag Cyclosporins.
US6187547B1 (en) * 1993-09-08 2001-02-13 Novartis Ag Assay kit
GB9624038D0 (en) * 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
US6017879A (en) * 1998-04-03 2000-01-25 B.M.R.A. Corporation B.V. Template associated NPY Y2-receptor agonists
USRE40987E1 (en) 1998-07-01 2009-11-17 Debiopharm S.A. Cyclosporin with improved activity profile
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
PT1150999E (pt) * 1999-02-05 2006-10-31 Debiopharm Sa Derivados da ciclosporina em que a sequencia peptidica contem pelo menos um aminoacido nao natural do tipo pseudo-prolina e metodo para preparacao dos mesmos
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
WO2001005819A1 (en) * 1999-07-15 2001-01-25 Kuhnil Pharm. Co., Ltd. Novel water soluble-cyclosporine conjugated compounds
EP1210121A2 (en) * 1999-08-24 2002-06-05 Cellgate Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties

Also Published As

Publication number Publication date
DE60208180D1 (de) 2006-01-26
ES2256450T3 (es) 2006-07-16
JP2004536051A (ja) 2004-12-02
DE60208180T2 (de) 2006-08-17
US20040138108A1 (en) 2004-07-15
BR0208923A (pt) 2004-04-27
CA2444278A1 (en) 2002-10-31
JP4588979B2 (ja) 2010-12-01
EP1379547A2 (fr) 2004-01-14
US6995139B2 (en) 2006-02-07
AU2002245996B2 (en) 2005-06-30
MXPA03009586A (es) 2004-05-24
KR100932859B1 (ko) 2009-12-23
ZA200307794B (en) 2004-07-19
UA75136C2 (en) 2006-03-15
CA2444278C (en) 2011-11-22
CN1507451A (zh) 2004-06-23
ATE313557T1 (de) 2006-01-15
KR20030094357A (ko) 2003-12-11
RU2290196C2 (ru) 2006-12-27
AU2002245996B8 (en) 2005-07-14
RU2003133742A (ru) 2005-03-20
EP1379547B1 (fr) 2005-12-21
WO2002085928A3 (fr) 2003-04-17
WO2002085928A2 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
IL158385A0 (en) Modified cyclosporin which can be used as a pro-drug and use thereof
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
HK1085667A1 (en) Non-nucleoside reverse transcriptase inhibitors
MY144318A (en) Methods of treating hiv infection.
HRP20010738B1 (en) N-cyanomethyl amides as protease inhibitors
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
AU3780901A (en) Pharmaceutical composition for muscular anabolism
WO2002094189A3 (en) Compositions and methods for treating or preventing convulsions or seizures
PL366800A1 (en) Tablet comprising cetirizine and pseudoephedrine
WO2003092632A3 (en) Cyclic peptide anti-cancer agents and methods
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
AU2002246983A1 (en) 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
EP1382612A4 (en) PROTEIN PARTICIPATING IN THE RESTORATION OF FERTILITY OF CYTOPLASMIC MALE STERILITY AND GENE CODING THE SAME
PT1603584E (pt) Aplidina para o tratamento de mieloma múltiplo
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
MXPA05009626A (es) Sistema de liberacion subcutanea, su proceso de preparacion y uso para el tratamiento de trastornos de deficiencia colinergica.
AU3739500A (en) Protease resistant flint analogs
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
NZ533738A (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
GB0221169D0 (en) Crystal
DE60015559D1 (de) Sentrin-spezifische menschliche protease senp1
GB0128071D0 (en) Medicament
UA32314A (uk) Спосіб лікування некротичного панкреатиту
UA62577C2 (en) Pollentar, pharmaceutical adaptogenic composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees